Nerve Ultrasound Comparison Between Transthyretin Familial Amyloid Polyneuropathy and Chronic Inflammatory Demyelinating Polyneuropathy

Nerve Ultrasound Comparison Between Transthyretin Familial Amyloid Polyneuropathy and Chronic Inflammatory Demyelinating Polyneuropathy

Backgrounds: Transthyretin familial amyloid polyneuropathy (TTR-FAP) is frequently misdiagnosed as chronic inflammatory demyelinating polyneuropathy (CIDP) because of similar phenotypes in the two diseases. This study was intended to identify the role of nerve ultrasonography in evaluating TTR-FAP a...

Full description

Bibliographic Details
Main Authors:	Kang Du, Ke Xu, Si Cheng, He Lv, Wei Zhang, Zhaoxia Wang, Yun Yuan, Lingchao Meng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Neurology
Subjects:	TTR-FAP CIDP transthyretin polyneuropathy ultrasonography
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2021.632096/full

Similar Items

Hereditary transthyretin amyloidosis
by: T. A. Adyan, et al.
Published: (2020-01-01)

A Clinical Case of the Hereditary Transthyretin Amyloidosis
by: E. V. Reznik, et al.
Published: (2021-05-01)

Transthyretin-Related Familial Amyloid Polyneuropathy: In the Light of New Developments
by: Arman Çakar, et al.
Published: (2017-09-01)

Atypical pure sensory forms of chronic inflammatory demyelinating polyneuropathies
by: Eugen Gavriliuc, et al.
Published: (2019-06-01)

Impact of Non-Cardiac Clinicopathologic Characteristics on Survival in Transthyretin Amyloid Polyneuropathy
by: Alejandra González‐Duarte, et al.
Published: (2020-03-01)

Selection of transthyretin amyloid inhibitors
by: Iakovleva, Irina
Published: (2016)

A New Folding Kinetic Mechanism for Human Transthyretin and the Influence of the Amyloidogenic V30M Mutation
by: Catarina S. H. Jesus, et al.
Published: (2016-08-01)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in a Patient with Diabetes: a primary care perspective
by: Jordan Dever, et al.
Published: (2020-10-01)

Treatment of pediatric chronic inflammatory demyelinating polyneuropathy: Challenges, controversies, and questions
by: Jay Desai, et al.
Published: (2015-01-01)

Anti-Neurofascin–Associated Nephrotic-Range Proteinuria in Chronic Inflammatory Demyelinating Polyneuropathy
by: Syed Bukhari, et al.
Published: (2020-11-01)

Inflammatory profiling of patients with familial amyloid polyneuropathy
by: Estefania P. Azevedo, et al.
Published: (2019-06-01)

The role of non-coding genetic variants on transthyretin gene transcription in transthyretin amyloidosis
by: Boldbaatar, Batbold
Published: (2021)

Tremor Associated with Chronic Inflammatory Demyelinating Polyneuropathy and Anti-Neurofascin-155 Antibodies
by: Laurent Bailly, et al.
Published: (2018-12-01)

Diagnosis and Treatment of Hereditary Transthyretin Amyloidosis (hATTR) Polyneuropathy: Current Perspectives on Improving Patient Care
by: Luigetti M, et al.
Published: (2020-02-01)

The use of IVIg in the treatment of inflammatory polyneuropathies and myasthenia gravis at The Walton Centre
by: Selim Kimyongur, et al.
Published: (2019-03-01)

Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis in patients with transthyretin amyloid polyneuropathy
by: Leslie Amass, et al.
Published: (2018-12-01)

Développement de stratégies d'analyse miniaturisée de biomarqueurs de la polyneuropathie amyloïde familiale à transthyrétine
by: Bataille, Jeanne
Published: (2017)

Oligomerization Profile of Human Transthyretin Variants with Distinct Amyloidogenicity
by: Ana Frangolho, et al.
Published: (2020-12-01)

Mechanisms of Transthyretin Inhibition of IAPP AmyloidFormation
by: Sanduni Wasana Jayaweera, et al.
Published: (2021-03-01)

The progress in diagnosis and treatment of transthyretin amyloid polyneuropathy
by: ZHU Xi⁃ying, et al.
Published: (2021-06-01)

Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort
by: Nath Pasutharnchat, et al.
Published: (2021-05-01)

Diphenyl-Methane Based Thyromimetic Inhibitors for Transthyretin Amyloidosis
by: Bokyung Kim, et al.
Published: (2021-03-01)

Vitreous Amyloidosis as the Presenting Symptom of Familial Amyloid Polyneuropathy TTR Val30Met in a Portuguese Patient
by: Mariana Seca, et al.
Published: (2014-03-01)

Prevalence of hereditary transthyretin amyloid polyneuropathy in idiopathic progressive neuropathy in conurban areas
by: Andreas Thimm, et al.
Published: (2019-09-01)

Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
by: Steven Law, et al.
Published: (2020-12-01)

Repurposing Benzbromarone for Familial Amyloid Polyneuropathy: A New Transthyretin Tetramer Stabilizer
by: Ellen Y. Cotrina, et al.
Published: (2020-09-01)

Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy
by: Juliane Klehmet, et al.
Published: (2019-06-01)

High PR3-ANCA positivity in a patient with chronic inflammatory demyelinating polyneuropathy
by: Masanori Kurihara, et al.
Published: (2017-03-01)

Evaluation of Mortality During Long-Term Treatment with Tafamidis for Transthyretin Amyloidosis with Polyneuropathy: Clinical Trial Results up to 8.5 Years
by: Giampaolo Merlini, et al.
Published: (2020-02-01)

Hereditary ATTR Amyloidosis in Austria: Prevalence and Epidemiological Hot Spots
by: Michaela Auer-Grumbach, et al.
Published: (2020-07-01)

Structural stabilization of transthyretin by a new compound, 6-benzoyl-2-hydroxy-1H-benzo[de]isoquinoline-1,3(2H)-dione
by: Takeshi Yokoyama, et al.
Published: (2015-12-01)

Chronic inflammatory demyelinating polyneuropathy: quality of life, sociodemographic profile and physical complaints
by: Patricia Leila dos Santos, et al.
Published: (2014-03-01)

Long-term Negative Psychological Impact of Presymptomatic Testing on Familial Amyloid Polyneuropathy
by: Ângela M. Teixeira Leite, et al.
Published: (2019-06-01)

Atypical Chronic Inflammatory Demyelinating Polyneuropathy
by: J Gordon Millichap
Published: (2010-11-01)

Autosomal-dominant transthyretin (TTR)-related amyloidosis is not a frequent CMT2 neuropathy “in disguise”
by: Marina Grandis, et al.
Published: (2018-10-01)

Electrodiagnostic patterns of demyelination and hughes functional grading in typical chronic inflammatory demyelinating polyneuropathy
by: Fatin Hatim Towman, et al.
Published: (2020-01-01)

Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy
by: Marcus Vinicius Pinto, et al.

Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants—A Potential Novel Biomarker of Disease Activity
by: Frauke Stascheit, et al.
Published: (2021-09-01)

Assessment of Expression of SOCS Genes in Acquired Immune-Mediated Polyneuropathies
by: Mohammad Taheri, et al.
Published: (2021-07-01)

Subacute Demyelinating Polyneuropathy
by: J Gordon Millichap
Published: (2005-06-01)